These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 367555)

  • 1. Hypercalcemia and cancer: an update.
    Murray TM; Josse RG; Heersche JN
    Can Med Assoc J; 1978 Oct; 119(8):915-20. PubMed ID: 367555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hypocalcemia in malignant diseases].
    Heidbreder E; Schafferhans K; Heidland A
    Klin Wochenschr; 1983 Aug; 61(16):773-83. PubMed ID: 6355639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial: Osteoclastic bone resorption and the hypercalcemia of cancer.
    Brewer HB
    N Engl J Med; 1974 Nov; 291(20):1081-2. PubMed ID: 4412968
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on the pathogenesis of cancer hypercalcemia.
    Laird Myers WP; Bockman R
    Trans Am Clin Climatol Assoc; 1977; 88():177-90. PubMed ID: 898535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hypercalcemia of cancer. Clinical implications and pathogenic mechanisms.
    Mundy GR; Ibbotson KJ; D'Souza SM; Simpson EL; Jacobs JW; Martin TJ
    N Engl J Med; 1984 Jun; 310(26):1718-27. PubMed ID: 6328302
    [No Abstract]   [Full Text] [Related]  

  • 6. Overview of hypercalcemia of malignancy.
    Solimando DA
    Am J Health Syst Pharm; 2001 Nov; 58 Suppl 3():S4-7. PubMed ID: 11757205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hypercalcemia associated with malignant neoplastic disorders: attempt at physiopathologic interpretation. 15 cases].
    Bloch-Michel H; Aristoff H; Gorins A; Dussart N
    Rev Rhum Mal Osteoartic; 1969 Apr; 36(4):174-90. PubMed ID: 5402944
    [No Abstract]   [Full Text] [Related]  

  • 8. Ectopic secretion of parathyroid hormone.
    Max MH; Lawrence PH
    Surg Gynecol Obstet; 1980 Mar; 150(3):411-8. PubMed ID: 6986669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Differential diagnosis and therapy of tumor-associated hypercalcemia].
    Thomas M; Schneider W
    Dtsch Med Wochenschr; 1989 Oct; 114(41):1576-81. PubMed ID: 2680409
    [No Abstract]   [Full Text] [Related]  

  • 10. Mechanisms of cancer-induced hypercalcemia.
    Rosol TJ; Capen CC
    Lab Invest; 1992 Dec; 67(6):680-702. PubMed ID: 1460860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor hypercalcemia and "ectopic hyperparathyroidism".
    Skrabanek P; McPartlin J; Powell D
    Medicine (Baltimore); 1980 Jul; 59(4):262-82. PubMed ID: 6993843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of cancer-related hypercalcemia: epidemiology and etiology.
    Muggia FM
    Semin Oncol; 1990 Apr; 17(2 Suppl 5):3-9. PubMed ID: 2185551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of calcium reabsorption observed in advanced breast cancer patients with hypercalcemia and multiple bone metastases.
    Kimura S; Adchi I; Yamaguchi K; Suzuki M; Shimada A; Sato Y; Nagaoka K; Abe K
    Jpn J Cancer Res; 1985 Apr; 76(4):308-14. PubMed ID: 2989061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of a parathyroid hormone analogue in the pathogenesis of malignant hypercalcemia].
    Rizzoli R; Buchs B; Pizurki L; Caverzasio J; Sappino AP; Vadas L; Arlot M; Bonjour JP
    Pathol Biol (Paris); 1990 Jun; 38(6):656-64. PubMed ID: 2197594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hypercalcemia and cancer].
    Coninx P; Grandfils F; Colin J; Lachapelle F; Andrien JM; Pirenne Y
    Rev Med Liege; 1974 May; 29(10):284-8. PubMed ID: 4365350
    [No Abstract]   [Full Text] [Related]  

  • 16. [Malignant tumors].
    Tanaka M; Abe K
    Nihon Rinsho; 1978 Oct; 36(10):3426-30. PubMed ID: 364097
    [No Abstract]   [Full Text] [Related]  

  • 17. Hypercalcemia of malignancy--new insights into an old syndrome.
    Esbrit P
    Clin Lab; 2001; 47(1-2):67-71. PubMed ID: 11214225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic efficacy of a soluble receptor activator of nuclear factor kappaB-IgG Fc fusion protein in suppressing bone resorption and hypercalcemia in a model of humoral hypercalcemia of malignancy.
    Oyajobi BO; Anderson DM; Traianedes K; Williams PJ; Yoneda T; Mundy GR
    Cancer Res; 2001 Mar; 61(6):2572-8. PubMed ID: 11289133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bisphosphonates for cancer patients: why, how, and when?
    Body JJ; Mancini I
    Support Care Cancer; 2002 Jul; 10(5):399-407. PubMed ID: 12136223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypercalcemia of cancer: an update.
    Goni MH; Tolis G
    Anticancer Res; 1993; 13(4):1155-60. PubMed ID: 8352538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.